funding

With $100M in new funding, Tia CEO says the ‘tide has turned’ for investing in women’s health

Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, CEO Carolyn Witte said investors’ perspectives are changing. 

Babyscripts raises $12M, plans to expand to all 50 states

The maternal care startup is backed by major health systems including MemorialCare Health System, whose innovation arm led the most recent funding round. Babyscripts offers a mobile app providing education and resources for the pregnancy and postpartum journey.

DotCom Therapy snags $13M to expand pediatric teletherapy services

The company, which partners with health systems and schools to provide virtual therapy services for kids, will use the Series A funds to expand. The round was led by New Capital Partners, with participation from LRVHealth and OSF Ventures.

UK pledges £5.4bn to NHS to ease COVID-19 treatment backlog

NHS England will get an extra £5.4 billion ($7.5 billion) in funding over the next six months to respond to COVID-19 and address a backlog in care caused by the pandemic, according to the UK government. The total includes £1 billion to get delivery of routine surgeries and treatments to patients delayed by COVID-19 back …

UK pledges £5.4bn to NHS to ease COVID-19 treatment backlog Read More »

PharmaShots Interview: Kaia Health’s Konstantin Mehl Shares Insight on the Funding to Transform the Treatment for MSK and COPD

In an interview with PharmaShots, Konstantin Mehl, President, CEO, and Founder at Kaia Health shared his views on the grant of $75M Series C funding to expand clinical capabilities & transform the treatment path for musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care in the US and EU. Shots: The funding will extend the …

PharmaShots Interview: Kaia Health’s Konstantin Mehl Shares Insight on the Funding to Transform the Treatment for MSK and COPD Read More »

Cadence launches with $41M, strikes partnership with LifePoint Health

The company offers a remote patient monitoring platform that enables clinicians to not only monitor patients at home but also provide personalized feedback via texts and video visits. The platform will be deployed at LifePoint Health facilities and used to deliver remote care to more than 100,000 patients.

Sema4 goes public via SPAC merger

With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.

Jefferson Health-backed Tendo Systems gains $50M to digitize patient journey

Tendo Systems, a company that is co-developing a digital engagement platform with provider organizations like Jefferson Health, raised $50 million in a new funding round. The funds will be used to advance the development of the platform, which aims to be the “OpenTable” of healthcare.

Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends

The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.

White House pledges $3 billion war chest for COVID antivirals

The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development of a new generation of antiviral therapies for COVID-19, as well as future viral threats. The plan was announced today by National Institute of Allergy and Infectious Diseases (NIAID) director and chief medical advisor Anthony Fauci, who …

White House pledges $3 billion war chest for COVID antivirals Read More »

Digital health startups saw better-than-expected revenue during the pandemic

According to a survey conducted by Catalyst @ Health 2.0, a whopping 41% of digital health companies said their revenue was above expectations last year. Despite reporting longer sales cycles, most companies still were optimistic about their business prospects going into 2021. 

Current Health nabs $43M to scale remote patient monitoring solution

The company is planning to use the newly raised funds to scale its remote patient monitoring solution, which integrates data from wearables and patient-reported symptoms to give clinicians a virtual view into patients’ health at home. The company’s plans also include doubling its workforce this year.

Novo Holding launches latest call for antibiotic investment proposals

With the focus on COVID-19 over the last year it’s easy to forget another deadly pandemic caused by antimicrobial resistance (AMR), which could lead to the most innocuous of infections becoming life threatening. The Novo Holding REPAIR Impact Fund is hoping to change this with its latest call for investment proposals to fight AMR. While …

Novo Holding launches latest call for antibiotic investment proposals Read More »

Advocate Aurora’s new investment arm to focus on aging, parenthood, wellbeing

Advocate Aurora Health has launched a subsidiary focused on making investments in companies that enhance health and wellbeing. The subsidiary has already made its first move, leading a $25 million funding round for a telenutrition provider.

Innovaccer gains unicorn status, plans to launch cloud platform

The health technology company’s valuation skyrocketed to $1.3 billion following its latest funding round. It plans to use the new funds to launch Innovaccer Health Cloud, which will aggregate and normalize data from different systems and support the development of interoperable apps.

LeanTaaS to use $130M to expand predictive analytics product suite, scale teams  

The health technology company raised a whopping $130 million in a Series D funding round. Its solutions aim to improve operational efficiency and better manage patient volume through predictive analytics, a growing need for providers as Covid-19 cases rise.

Minervax raises €47.4m in Series B funding round for GBS shot

Denmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its novel group B streptococcus (GBS) vaccine into mid-stage clinical trials. When and if the pandemic finally recedes there will still be an ongoing issue with a dearth of new antibiotics and a growing number of bacterial strains …

Minervax raises €47.4m in Series B funding round for GBS shot Read More »

Sinovac raises $515m to boost production of potential COVID-19 vaccine

China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion. According to press reports Sino Biopharmaceutical, a Hong Kong-listed generics firm, acquired a 15% stake in a subsidiary of Sinovac. Sinovac has a coronavirus vaccine in late-stage development, which is undergoing large-scale …

Sinovac raises $515m to boost production of potential COVID-19 vaccine Read More »

Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche

Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche. The company is developing four phase 2 drugs brought in from Roche after the big Swiss pharma decided somebody else should take the risk of developing them. Roche, which decided the products were surplus to …

Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche Read More »

WELL Health raises $45M, taps former Haven exec as new senior VP

The company, a facilitator of patient-clinician communication, plans to use the funds to bring new features and capabilities to market, as well as build strategic partnerships. It has also added Dr. Dana Gelb Safran as senior vice president of value-based care and population health.

Sidekick Health raises $20m to fund digital therapeutics expansion

Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it plans to use to develop its product offering. Based in Iceland, Sidekick said the oversubscribed funding round was led by Wellington Partners and Asabys Partners through its SAHII fund, with existing investors Novator and Frumtak Ventures. The …

Sidekick Health raises $20m to fund digital therapeutics expansion Read More »

SparingVision raises €44.5m for retinitis pigmentosa gene therapy

French biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare ocular disease. The round was led by 4BIO Capital and UPMC Enterprises with Jeito Capital and Ysios Capital joining. Current investors Bpifrance and Foundation Fighting Blindness also participated. In a statement, the company said funds will be …

SparingVision raises €44.5m for retinitis pigmentosa gene therapy Read More »

Insights+ Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer

Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has developed a platform to deliver novel technology to pathologists to …

Insights+ Interview: Paige’s CEO, Leo Grady Shares Insights on its Series B Funding and the FDA’s 510(k) Clearance for FullFocus Viewer Read More »